| Product containing precisely aluminium hydroxide 58.2 milligram/1 milliliter and magnesium hydroxide 19.6 milligram/1 milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | | Aluminum hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxethazaine 2 mg/mL oral suspension | | Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension
|
| | Id | 1234931005 | | Status | Defined |
| Has BoSS | Oxethazaine | | Has concentration strength denominator unit | mL | | Has concentration strength numerator unit | mg | | Has precise active ingredient | Oxethazaine |
|
